The possibility of replacing threonine by nitrogen-free analogues in a diet of patients with diabetic nephropathy: a biochemical aspect

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

There is a well established theory that an essential amino acid of threonine is incapable of transamination. According to this theory, in a diet of patients who suffer from nephropathy, including diabetic threonine, is not replaced by its ketoanalogue. However, transamination of threonine, in the human organism in particular, has been discovered by a number of researchers. This suggests that there is a possibility of replacing threonine by its nitrogen-free analogues in nutrition of patients with nephropathy. At the same time nitrogen-free analogues of all amino acids can be subject to oxidative decomposition subsequently not only up to the finishing products, but they can also form glucose or ketone bodies, or both. Depending on this, amino acids are divided into glucogenic only, ketogenic only or both at the same time.

With reference to diabetes this becomes especially important as introduction of glucogenic amino acids and their nitrogen-free analogues has a positive effect, whereas that of ketogenic amino acids and their nitrogen-free analogues is inadmissible. This is caused by the fact that before being transformed into glucose, glucogenic amino acids are transformed into one or another component of Krebs cycle or into the pyruvic acid which is in balance with the components which stimulates oxydation of acetyl coenzyme A and, therefore, ketone bodies.

Ketose with reference to diabetes can be caused by two reasons. While the main source of energy of a healthy person is carbohydrate, in case with diabetes fats perform the function — being oxydized intensively, they form a great number of ketone bodies. The second reason is a decrease in the formation of oxaloacetic acid (Krebs cycle catalyst) from pyruvic acid due to a decrease in the formation of the latter from glucose and an increase in the use of the components of the Krebs cycle for gluconeogenesis.

Ketose causes a sharp shift of pH value to more acidity as a result of accumulation of the acetoacetic acid and the β-hydroxybutyric acid in blood and narcotic actions of the third ketonic body — acetone. The reason for lethal outcome with reference to diabetes is diabetic coma caused by a sharp shift of pH value to more acidity, which disturbs the work of the ferments. Threonine has a strong glucogenic effect in the complete absence of a ketogenic effect on the human body. In this respect, nitrogen-free analogues of threonine do not differ from it.

Full Text

Restricted Access

About the authors

Andrey V. Malinovskiy

Special design technological bureau “Biofizpribor”, Saint Petersburg branch of the Experimental-production workshops of Federal Biomedical Agency

Author for correspondence.
Email: malinovskiy.andrey@yandex.ru
Russian Federation, Saint Petersburg

References

  1. Bellizzi V, Calella P, Hernández JN, et al. Safety and effectiveness of low-protein diet supplemented with ketoacids in diabetic patients with chronic kidney diseas. BMC Nephrol. 2018;19(1):110. doi: 10.1186/s12882-018-0914-5
  2. Elliott DF, Neuberger A. The irreversibility of the deamination of threonine in the rabbit and rat. Biochem J. 1950;46(2):207–210. doi: 10.1042/bj0460207
  3. Koppe L, Cassani de Oliveira M, Fouque D. Ketoacid analogues supplementation in chronic kidney disease and future perspectives. Nutrients. 2019;11(9):2071. doi: 10.3390/nu11092071
  4. Meltzer HL, Sprinson DE. The synthesis of 4-C14, N15-L- threonine and a study of its metabolism. J Biol Chem.1952;197(1):461–473.
  5. Noguchi T, Okuno E, Kido R. Idenity of isoenzyme 1 of histidine-pyruvate aminotransferase with serine-pyruvate aminotransferase. Biochem J. 1976;159(3):607–613. doi: 10.1042/bj1590607
  6. Ishikawa T, Okuno E, Tsujimoto M, et al. Kynurenine-pyruvate aminotransferase in rat kidney and brain. Adv Exp Med Biol. 1991;294:567–572. doi: 10.1007/978-1-4684-5952-4_68
  7. Hsiehs B, Tolbert NE. Glyoxylate aminotransferase in peroxisomes from rat liver and kidney. J Biol Chem. 1976;251(14):4408–4415.
  8. Okuno E, Minatogawa Y, Nakamura M, et al. Crystallization and characterization of human liver kynurenine-glyoxylate aminotransferase. Identity with alanine-glyoxylate aminotransferase and serine-pyruvate aminotransferase. Biochem J. 1980;189(3):581–590. doi: 10.1042/bj1890581
  9. Okuno E, Tsujimoto M, Nakamura M, Kido R. 2-Aminoadipate-2-oxoglutarate aminotransferase isoenzymes in human liver:a plausible physiological role in lysine and tryptophan metabolism. Enzyme Protein. 1993;47(3):136–148. doi: 10.1159/000468669
  10. Malinovsky AV. Does threonine possess any ketogenic action? Problems of Biological, Medical and Pharmaceutical Chemistry. 2020;23(6):34–39. (In Russ.). doi: 10.29296/25877313-2020-06-06
  11. Bird MI, Nunn PB. Metabolic homeostasis of L-threonine in the normally fed rat. Biochem J. 1983;214(3):687–693. doi: 10.1042/bj2140687
  12. Laver WG, Neuberger A, Scott JJ. α-Amino-β-keto-acids. Part II. Rates of decarboxylation of the free acids and the behaviorer of derivates on titration. Journal of the Chemical Society. 1959:1483–1491.
  13. Pagani R, Guerranti R, Leoncini R, Marinello E. Activation and inhibition of rat liver L-threonine dehydrogenase. Ital J Biochem. 1990;39(2):108.
  14. Pagani R, Guerranti R, Righi S, et al. Identification of a mitochondrial inhibitor of rat liver L-threonine dehydrogenase. Biochem Biophys Actа. 1995;244(1):49–52. doi: 10.1016/0304-4165(94)00192-z
  15. Guerranti R, Pagani R, Neri S, et al. Inhibition and regulation of rat liver L-threonine dehydrogenase. By different fatty acids and their derivates. Biochem Biophys Acta. 2001;1568(1):45–52. doi: 10.1016/s0304-4165(01)00197-0
  16. Malinovsky AV. Is threonine an essential amino acid? Preventive and Clinical Medicine. 2011;(4(41)):116–119. (In Russ.)
  17. Malinovsky AV. Reason for indispensability of threonine in humans and other mammals in comparative aspect. Biochemistry (Moscow). 2017;82(9):1055–1060.
  18. Malinovsky AV. Why threonine is an essential amino acid in mammals and birds: studies at the enzyme level. Biochemistry (Moscow). 2018;83(7):795–799. doi: 10.1134/S0006297918070039
  19. Malinovsky AV. Reasoning of generation of threonine indispensability in evolutionary aspect. Tsitologiya. 2019;61(7):521–528. (In Russ.). doi: 10.1134/S0041377119070058
  20. Beryozov TT. Exchange of amino acids of normal tissues and that of malignant tumours. Moscow: Medicine; 1969. (In Russ.)
  21. Beryozov TT, Korovkin BF. Biological Chemistry. Moscow: Medicine; 2004. (In Russ.)
  22. Barrett G. Chemistry and biochemistry of the amino acids. UK, London; New York Chapman and Hall; 2012.
  23. Growdon JH, Nader TM, Schoenfeld J, Wurtman RJ. L-threonine in the treatment of spasticity. Cln Neuropharmacol. 1991;14(5):403−412. doi: 10.1097/00002826-199110000-00003
  24. Lee A, Patterson V. Double-blind study of L-threonine in patients with spinal spasticity. Acta Neurol Scand. 1993;88(5):334−338. doi: 10.1111/j.1600-0404.1993.tb05353.x
  25. Edgar AJ. The human L-threonine-3-dehydrogenase gene is an expressed pseudogene. BMC Genet. 2002;3:18. doi: 10.1186/1471-2156-3-18
  26. Han C, Cai T, Tagle DA, et al. Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II. Biosci Rep. 2008;28(4):205–215. doi: 10.1042/BSR20080085
  27. Shah AP, Kalantar-Zadeh K, Kopple JD. Is there a role for ketoacid supplements in the management of CKD? Am J Kidney Dis. 2015;65(5):659–673. doi: 10.1053/j.ajkd.2014.09.029

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Threonine breakdown in the cytosol

Download (53KB)
3. Fig. 2. Threonine breakdown in mitochondria. Аcetyl CoA — acetyl coenzyme A; NAD — nicotinamid asenin dinucleotide; NADH — reduced form of nicotinamid asenin dinucleotide; HSKoA — coenzyme A

Download (98KB)
4. Fig. 3. Transamination of threonine with pyruvic acid in the human liver

Download (92KB)
5. Fig. 4. Transamination of threonine with α-ketoglutaric acid in the human liver

Download (96KB)

Copyright (c) 2022 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 71733 от 08.12.2017.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies